We know that treating diabetes can be complex due to varying degrees of insulin resistance and impaired insulin secretion, as well as the influence of nongenetic and genetic factors. Current guidelines recommend glucose-lowering treatment based on clinical characteristics, but this one-size-fits-all approach is no longer sufficient. Join Dr Om Lakhani, a leading expert in diabetes management, for a talk on Precision Medicine for Type 2 Diabetes. Discover how this approach can identify predictors of differential drug responses and maximize therapeutic benefit while limiting risks. Don't miss this opportunity to learn from a leading expert in the field of diabetes management!

A New Era in Diabetes Treatment: Precision Medicine

Get ready for the ultimate showdown in endocrinology! Join us for "The Endocrine Quiz", hosted by Dr. Om Lakhani, Consultant Endocrinologist at Zydus Hospital. Test your knowledge and compete against your peers for a chance to win exciting prizes. This thrilling event takes place only the Medflix app. Don't miss out on this exciting opportunity to showcase your endocrine expertise!

The Endocrine Quiz

Association of Physicians of India - APICON 2023 & Medflix jointly present India's largest LIVE medical quiz series! Prepare for the most thrilling quizzes of the year! 7 days, 7 specialties & unlimited learning. With two faculty Quizmasters for this edition, the fun will be doubled. While Dr. Om Lakhani will assess our clinical endocrinology knowledge, Dr. Sanjeev Phatak will test our understanding of diabetes. Join in, play along, and obtain insightful clinical knowledge while winning fun cash prizes and taking home your API certificate of attendance. Experience the joy of learning medicine, tune in on 13th Jan at 9PM! 

APIQUIZ : Endocrinology Edition

The incidence of obesity and diabetes, also known as the 'twin epidemics', is a rising global issue, particularly in developed nations. Therefore, cutting-edge therapeutic modalities are required. As the only dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptor agonist, tirzepatide, also referred to as a 'twincretin', can significantly lower glycemic levels, improve insulin sensitivity, as well as reduce body weight by more than 20% and improve lipid metabolism. On the other hand, we have the USFDA and the EMA approved Semaglutide, a novel second-generation long-acting GLP-1RA for once-weekly subcutaneous administration, as an adjunct to diet and exercise in individuals with type 2 diabetes that is not well controlled. Join us LIVE as renowned endocrinologists Dr. Om Lakhani and Dr. Mayur Agrawal square off to discuss the benefits and drawbacks of each treatment.

Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes

The growing incidence of type 2 diabetes (T2D) is a significant health concern, representing 90% of diabetes cases worldwide. Over the past decade, the rise of diabetes technologies, including dosing advisors, continuous glucose monitoring systems, insulin pumps and automated insulin delivery systems, has led to great improvements in the therapies available, particularly to those requiring insulin. As we look to what’s ahead in new diabetes technology for 2022, many may experience a sense of déjà vu. Join us for another interesting session as Dr. Om Lakhani discusses about currently available diabetes technologies as well as future prospects.

Technology in Diabetes- A glimpse into the near Future

Dr. Om Lakhani: GLP1a are the most proven therapy in such a high risk patient in such a scenario 
Dr. Pankaj Agarwal: DDP4 i are safer, oral, inexpensive and better alternative in such patients. 
Dr. Banshi Saboo: AGI/ Meglinitide analogue are safer bet in view of CKD

CAD- DIABETES- CKD - GLP1a /DPP4/AGI

Bariatric surgery involves changing the patient's digestive system to help them lose weight and increase overall health. Sleeve gastrectomy reduces the patient's stomach by 15% of its original size. Dr. Narwaria, one of the country's leading bariatric surgeons and founder of Asian Bariatrics, will walk us through the Sleeve Gastrectomy procedure. Dr. Om Lakhani, an endocrinologist at Zydus Hospitals, will join him to discuss the broader significance of obesity surgeries. Join us live and exclusive on Medflix!

Sleeve Gastrectomy: Explained

Gone are the days when patients were classified as type 1, type 2 diabetes  and others. With Increasing understanding of the pathogenesis of diabetes mellitus, diabetes is now understood to be a 'spectrum that unifies the disease rather than "buckets" which divides it. In this didactic talk we are going to discuss the unifying theory for understanding the pathogenesis of diabetes, newer classification and subclassifications of diabetes based on the clinical clues that tell us about the underlying pathophysiology. For those who are dealing with patients with diabetes mellitus on day to day basis this lecture will prove to be very useful for better management of patients.

Dr. Om Lakhani

22

18.9k

386.4k

4.6

Sessions Taken

1.5k

4.6

934

4.6

1.1k

4.6

492

4.5

460

4.5

651

4.6

354

4.3

736

4.7